WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh

World Vape Show by 2FIRSTS
Jun.14.2024
WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
World Vape Show in Dubai featured ANYX brand leader Sanking discussing market performance, new products, and future plans.

The World Vape Show was held at the Dubai World Trade Center from June 12th to 14th. During the event, 2FIRSTS had a conversation with Sanking, the head of Anyx, a brand under the Yijiate Group, where he discussed the market performance of Anyx, new products, and future development plans.

WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
ANYX booth | Image source: 2FIRSTS

 

According to Sanking, the ANYX brand specializes in pod systems, including both open and closed systems, and also has entered the disposable e-cigarette market. The brand is continuously innovating its technology and has recently launched four new products, including Anyx-pro, Anyx-go, Anyx-polo, and Anyx-max.

WVS | ANYX: Latest Product is Based on Atomization Technology G-mesh
ANYX booth | Image source: 2FIRSTS

 

Sanking stated that ANYX primarily focuses its market in Europe, particularly in Italy and Spain, as well as in South America, the Middle East, and Southeast Asia, with the best performance seen in the Italian market. The brand name "ANYX" combines "any + possible," symbolizing endless possibilities and emphasizing user needs and perception.

 

This is ANYX's first participation in the world e-cigarette exhibition in Dubai. The Middle East market is a completely new territory for ANYX, as the brand only started expanding into this market at the end of 2022. Sanking stated that despite being a relatively new brand, the Middle East market will be a strategic focus for future extensive deployment.

 

At this exhibition, ANYX showcased its latest atomization core technology G-mesh and the products using it. While ANYX introduced a large-screen e-cigarette based on cartridge replacement, it remains cautious towards disposable large-screen e-cigarettes due to concerns about resource waste and environmental issues.

 

Sanking stated that the Middle East market has tremendous potential, and ANYX is currently in discussions with multiple local distributors for collaboration. The brand's plan is to combine online and offline experiences and user operations to increase market share. In the future, ANYX will launch products that better cater to the preferences of local consumers based on market demand, and will collaborate deeply with local partners.

 

Sanking stated that ANYX will focus on the European market and continue to explore opportunities in other emerging markets in the future. The brand will introduce products tailored to consumer demands based on market conditions, aiming to enhance user experience through technological innovation.

 

Finally, Sanking gave high praise to the e-cigarette exhibition in Dubai, considering it the largest in the world with significant influence. The large number of exhibitors, distributors, and visitors, along with intense competition, reflects the industry's enormous potential and development trends.

 

He called on all industry participants to focus on the product itself and user experience, rather than solely concentrate on price wars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14